Price target upside
Alnylam Pharmaceuticals Price Target: +59.9% vs Current Price
ALNY target gap is +59.9% from $231.46 to $370.20. As of 2026-08-24.
Direct answer
Alnylam Pharmaceuticals's analyst target implies +59.9%.
The average target is $370.20 compared with a recorded current price of $231.46.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 24, 2026.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $231.46
- Average price target
- $370.20
- High price target
- $536.00
- Low price target
- $230.00
- Low target gap
- -0.6%
- Target upside
- +59.9%
- High target gap
- +131.6%
- Target range width
- 132.2%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Alnylam Pharmaceuticals's average target imply?
Alnylam Pharmaceuticals's average target is $370.20 versus a recorded price of $231.46. The difference is +59.9%.
How far are Alnylam Pharmaceuticals's low and high targets from the recorded price?
The low target implies -0.6%, while the high target implies +131.6%.
How many analysts are included in Alnylam Pharmaceuticals's consensus?
The verified consensus includes 26 analysts.
How is Alnylam Pharmaceuticals's target upside or downside calculated?
The average target of $370.20 is divided by the recorded price of $231.46, then one is subtracted to produce +59.9%. This does not guarantee a future return.
When was Alnylam Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.